| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |